OTCMKTS:TATYY - Tate & Lyle Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 5 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$34.78
▼ -0.82 (-2.30%)
1 month | 3 months | 12 months
Get New Tate & Lyle Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TATYY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TATYY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Tate & Lyle in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $34.78.
Hold
The current consensus among 6 contributing investment analysts is to hold stock in Tate & Lyle. This rating has held steady since April 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/12/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/10/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/9/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/8/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/6/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/4/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
11/3/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings
12/3/2020

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
11/18/2020BarclaysInitiated CoverageEqual Weight
i
11/11/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
i
11/10/2020Berenberg BankReiterated RatingHold
i
11/6/2020Credit Suisse GroupReiterated RatingNeutral
i
11/6/2020InvestecUpgradeSell ➝ Hold
i
7/24/2020BarclaysReiterated RatingOverweight
i
5/28/2020BarclaysReiterated RatingOverweight
i
5/6/2020Berenberg BankReiterated RatingHold
i
5/6/2020InvestecDowngradeHold ➝ Sell
i
5/5/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
i
3/31/2020Jefferies Financial GroupUpgradeHold ➝ Buy
i
3/17/2020InvestecUpgradeSell ➝ Hold
i
12/8/2019Jefferies Financial GroupUpgradeUnderperform ➝ Hold
i
11/25/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy
i
6/3/2019Jefferies Financial GroupDowngradeHold ➝ Underperform
i
6/13/2018Jefferies Financial GroupDowngradeBuy ➝ Hold
i
2/13/2018Kepler Capital MarketsUpgradeHold ➝ Buy
i
2/9/2018Societe GeneraleUpgradeHold ➝ Buy
i
10/23/2017Jefferies Financial GroupUpgradeHold ➝ Buy
i
9/26/2017InvestecUpgradeSell ➝ Hold
i
6/30/2017Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold
i
6/7/2017Jefferies Financial GroupDowngradeBuy ➝ Hold
i
4/12/2017Numis SecuritiesDowngradeAdd ➝ Hold
i
4/12/2017Numis SecuritiesReiterated RatingAdd ➝ Hold
i
12/16/2016Shore CapitalReiterated RatingHold
i
11/10/2016CitigroupReiterated RatingNeutral
i
11/9/2016BNP ParibasDowngradeNeutral ➝ Underperform
i
11/7/2016Societe GeneraleDowngradeBuy ➝ Hold
i
11/3/2016Davy ResearchReiterated RatingNeutral
i
6/28/2016Societe GeneraleReiterated RatingBuy
i
6/22/2016Davy ResearchReiterated RatingNeutral
i
5/26/2016Shore CapitalReiterated RatingHold
i
5/25/2016Liberum CapitalReiterated RatingBuy
i
2/11/2016Shore CapitalReiterated RatingHold
i
2/11/2016Davy ResearchReiterated RatingUnderperform
i
(Data available from 12/3/2015 forward)
Tate & Lyle logo
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; health and wellness ingredients; and stabilizers. It also provides industrial starches for paper, packaging, and industrial adhesives; acidulants, such as citric acid; and commodities comprising corn gluten feed and meal for animal nutrition, as well as corn oil and ethanol. In addition, the company is involved in the treasury and insurance businesses; and provision of research and development services. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $34.78
$34.78
$34.95

50 Day Range

MA: $33.94
$31.02
$35.73

52 Week Range

Now: $34.78
$23.57
$42.50

Volume

786 shs

Average Volume

1,733 shs

Market Capitalization

$4.07 billion

P/E Ratio

11.75

Dividend Yield

2.39%

Beta

0.8